Clinical Trial

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Study acronym: SLIM-2
Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multicenter, 1:1 randomized, investigator initiated study. Goal of this study is to examine the safety of uninterrupted periprocedural DOAC use.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-07-20.
Status change: Not Yet Recruiting → Recruiting 2026-05-26
Trial Details
NCT Number NCT04977076
Lead Sponsor Zuyderland Medisch Centrum
Conditions Atrial Fibrillation, Coronary Artery Disease, Anticoagulants
Enrollment 1,270 participants
Start Date 2022-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29